Metformin Sandoz

Metformin, the active ingredient in Metformin Sandoz, is a biguanide presented as an oral tablet for oral use. It is employed to improve glycemic control in adults with type 2 diabetes mellitus, helping to lower elevated blood glucose levels and is commonly used as first‑line therapy in combination with diet and exercise.

GNH USA supplies Metformin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to essential antidiabetic medication for health‑care systems across multiple regions.

Metformin Sandoz is an oral antidiabetic medication used in the management of type 2 diabetes mellitus. - Type 2 diabetes mellitus (monotherapy): lowers fasting plasma glucose and HbA1c levels. - Combination with sulfonylureas or meglitinides: provides additional glucose reduction when monotherapy is insufficient. - Combination with insulin: helps reduce the required insulin dose and mitigates weight gain associated with insulin therapy.

Metformin Sandoz may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and diarrhea. - Metallic taste: transient metallic sensation in the mouth. - Loss of appetite: reduced desire to eat. - Weight loss: modest decrease in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Vitamin B12 deficiency: may develop with long‑term therapy. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: such as Stevens‑Johnson syndrome.

When prescribing Metformin Sandoz, clinicians should consider several precautionary measures to ensure safe use. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: avoid use in patients with significant liver disease. - Cardiovascular status: monitor for signs of heart failure, especially in the elderly. - Contraindications: do not use in patients with known hypersensitivity to metformin. - Lactic acidosis risk: discontinue before any radiographic procedures involving iodinated contrast. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Metformin Sandoz can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol excess: enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal function, requiring dose adjustment. - Diuretics: can reduce renal clearance of metformin. - Beta‑blockers: may mask hypoglycemia symptoms.